Literature DB >> 17306875

Leber congenital amaurosis caused by an RPGRIP1 mutation shows treatment potential.

Samuel G Jacobson1, Artur V Cideciyan, Tomas S Aleman, Alexander Sumaroka, Sharon B Schwartz, Alejandro J Roman, Edwin M Stone.   

Abstract

PURPOSE: To determine the treatment potential in Leber congenital amaurosis (LCA) resulting from an RPGRIP1 (retinitis pigmentosa GTPase regulating-interacting protein 1) mutation, a form of LCA with recent gene therapy success in an animal model.
DESIGN: Case report of a rare genetic eye disease investigated for intervention potential. PARTICIPANTS: A 19-year-old man with LCA.
METHODS: We studied the retinal structure and function in an LCA patient with a novel homozygous Val1211Glu mutation in the RPGRIP1 gene using optical coherence tomography and colocalized dark-adapted thresholds. MAIN OUTCOME MEASURE: Optical coherence tomography results.
RESULTS: Central retinal laminar architecture was preserved, and there was a measurable outer nuclear layer. The retained retinal structure corresponded to the region of visual sensitivity. With increasing eccentricity, there was no measurable visual function, and retinal laminar disorganization suggested a remodeling process.
CONCLUSIONS: The RPGRIP1-LCA patient has treatment potential for a gene replacement strategy if targeted to central, but not pericentral or peripheral, retina. The results differ from similarly studied RPE65-LCA and CRB1-LCA patients. Preclinical progress toward therapy in LCA patients warrants detailed structure-function studies in humans to determine feasibility and candidacy for clinical trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306875     DOI: 10.1016/j.ophtha.2006.10.028

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  22 in total

1.  Task-dependent V1 responses in human retinitis pigmentosa.

Authors:  Yoichiro Masuda; Hiroshi Horiguchi; Serge O Dumoulin; Ayumu Furuta; Satoru Miyauchi; Satoshi Nakadomari; Brian A Wandell
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-05       Impact factor: 4.799

2.  Gene therapy using self-complementary Y733F capsid mutant AAV2/8 restores vision in a model of early onset Leber congenital amaurosis.

Authors:  Cristy A Ku; Vince A Chiodo; Sanford L Boye; Andrew F X Goldberg; Tiansen Li; William W Hauswirth; Visvanathan Ramamurthy
Journal:  Hum Mol Genet       Date:  2011-08-31       Impact factor: 6.150

Review 3.  Leber congenital amaurosis caused by mutations in GUCY2D.

Authors:  Shannon E Boye
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-25       Impact factor: 6.915

4.  A novel exon 17 deletion mutation of RPGRIP1 gene in two siblings with Leber congenital amaurosis.

Authors:  Takahide Suzuki; Takuro Fujimaki; Ai Yanagawa; Eisuke Arai; Keiko Fujiki; Yuko Wada; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2014-08-07       Impact factor: 2.447

5.  Replacement gene therapy with a human RPGRIP1 sequence slows photoreceptor degeneration in a murine model of Leber congenital amaurosis.

Authors:  Basil S Pawlyk; Oleg V Bulgakov; Xiaoqing Liu; Xiaoyun Xu; Michael Adamian; Xun Sun; Shahrokh C Khani; Eliot L Berson; Michael A Sandberg; Tiansen Li
Journal:  Hum Gene Ther       Date:  2010-08       Impact factor: 5.695

6.  Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Igor V Peshenko; Alexander Sumaroka; Elena V Olshevskaya; Lihui Cao; Sharon B Schwartz; Alejandro J Roman; Melani B Olivares; Sam Sadigh; King-Wai Yau; Elise Heon; Edwin M Stone; Alexander M Dizhoor
Journal:  Hum Mol Genet       Date:  2012-10-03       Impact factor: 6.150

7.  Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone-rod dystrophy.

Authors:  Elsa Lhériteau; Lolita Petit; Michel Weber; Guylène Le Meur; Jack-Yves Deschamps; Lyse Libeau; Alexandra Mendes-Madeira; Caroline Guihal; Achille François; Richard Guyon; Nathalie Provost; Françoise Lemoine; Samantha Papal; Aziz El-Amraoui; Marie-Anne Colle; Philippe Moullier; Fabienne Rolling
Journal:  Mol Ther       Date:  2013-10-04       Impact factor: 11.454

8.  Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Elizabeth A M Windsor; Waldo Herrera; D Alan White; Shalesh Kaushal; Anjani Naidu; Alejandro J Roman; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

9.  Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Sharon B Schwartz; Alejandro J Roman; Elizabeth A M Windsor; Janet D Steinberg; Kari Branham; Mohammad Othman; Anand Swaroop; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

10.  The RPGRIP1-deficient dog, a promising canine model for gene therapy.

Authors:  Elsa Lhériteau; Lyse Libeau; Knut Stieger; Jack-Yves Deschamps; Alexandra Mendes-Madeira; Nathalie Provost; Francoise Lemoine; Cathryn Mellersh; N Matthew Ellinwood; Yan Cherel; Philippe Moullier; Fabienne Rolling
Journal:  Mol Vis       Date:  2009-02-18       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.